Hereditary nonpolyposis colorectal cancer (HNPCC) poses a major public health problem wherein very little is known about the gross, microscopic, or histochemical premorbid pathology of the colonic mucosa in at risk patients. We shall take advantage of our resource of well-documented HNPCC kindreds to select 100 patients between the ages of 30 and 50 who are at 50% risk for this disease. Each of these individuals will undergo colonoscopy with multiple mucosal biopsies from cecum to rectum. Similar studies will be obtained on 100 patients with nonfamilial colon cancer and 20 normal controls with negative family histories of colon cancer. Detailed biochemical (lectin binding, tritiated thymidine uptake) and histopathologic (dysplastic changes, adenomatous changes, alterations in mucin secretion) parameters will be assessed in these tissues in a double-binded manner. Concurrently we will provide intensive education about the natural history of HNPCC and our strategies for surveillance and management of these patients and their relatives for their family physicians as well as followup as to the effect of such intervention. OUr experimental design will provide a basis for statistical analysis of the study population, the comparison group, and normal controls, utilizing the SYSDAT data analysis program for discriminant analysis to drive the function(s) that best differentiates cancer affected individuals from controls. That function will then be applied to the at risk group in order to determine if this group is heterogeneous and regard to the pathologic variables,and if there is bimodality of the discriminant score in the at risk group. These methods will allow comparison of the various parameters studies between the at risk, affected, and normal controls. We believe that this project could provide abundant new information as to the spectrum of premalignant abnormalities in HNPCC. These findings, coupled with education and surveillance programs, could have significant implications for cancer etiology, carcinogenesis, and control for the general population.
Lynch, H T; Smyrk, T C; Lanspa, S J et al. (1993) Cancer control problems in the Lynch syndromes. Dis Colon Rectum 36:254-60 |
Lynch, H T; Smyrk, T C; Watson, P et al. (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104:1535-49 |
Lynch, H T; Smyrk, T C; Watson, P et al. (1992) Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis? Dis Colon Rectum 35:411-21 |
Lanspa, S J; Jenkins, J X; Watson, P et al. (1992) Natural history of at-risk Lynch syndrome family members with respect to adenomas. Nebr Med J 77:310-3 |
Lynch, H T; Watson, P; Smyrk, T C et al. (1992) Colon cancer genetics. Cancer 70:1300-12 |
Lanspa, S J; Rouse, J; Smyrk, T et al. (1992) Epidemiologic characteristics of the flat adenoma of Muto. A prospective study. Dis Colon Rectum 35:543-6 |
Lynch, H T; Cavalieri, R J; Lynch, J F et al. (1992) Gynecologic cancer clues to Lynch syndrome II diagnosis: a family report. Gynecol Oncol 44:198-203 |
Lynch, H T; Smyrk, T; Watson, P et al. (1991) Hereditary colorectal cancer. Semin Oncol 18:337-66 |
Lynch, H T; Lynch, J F (1991) Familial factors and genetic predisposition to cancer: population studies. Cancer Detect Prev 15:49-57 |
Lynch, H T; Richardson, J D; Amin, M et al. (1991) Variable gastrointestinal and urologic cancers in a Lynch syndrome II kindred. Dis Colon Rectum 34:891-5 |
Showing the most recent 10 out of 25 publications